Grant: CIHR Fellowship
University of Toronto
$135,000.00
The Impact of HIV-1 and Malaria Co-infection on Angiogenesis, Fetal Development and Pregnancy Outcome in Sub-Saharan Africa.
FY 2011-12
Summary
Approximately 70% of people infected with HIV reside in sub-Saharan Africa. Women are particularly susceptible to HIV, with HIV rates 3 to 6-times higher in young women than men. Sub-Saharan Africa is also home to 30 million women at risk of contracting malaria during pregnancy each year and HIV increases the severity of malaria in pregnancy. When a mother is HIV positive, her fetus is at increased risk of being born growth restricted and of contracting HIV. Given the overlap between malaria and HIV in sub-Saharan Africa, we believe that malaria in pregnancy may increase the risk of the fetus contracting HIV from its mother. We believe this may occur as malaria initiates an immune response that activates fetal immune cells making them more susceptible to HIV infection. Further, malaria is known to increase the amount of HIV virus in the body, which relates to increased risk of transmission.
During pregnancy, angiogenic factors-proteins that circulate and are directly measureable in the blood- are responsible for coordinating the formation of blood vessels. Altered levels of these angiogenic factors have been associated with impaired fetal growth in preeclampsia and malaria, two major causes of fetal growth restriction globally. HIV is also associated with fetal growth restriction and we hypothesize that altered levels of angiogenic factors may contribute to HIV-related growth restriction.
In the work proposed, we will recruit and follow women throughout pregnancy. At antenatal visits, women will receive standard care including the administration of antiretroviral drugs to limit the risk of the fetus contracting HIV. In addition, a small blood sample will be collected for study purposes. We will measure whether changes in angiogenic proteins in HIV positive women are related to fetal growth restriction and we will determine whether malaria increases the ability of HIV to invade fetal cells.
Department
Program
CIHR Fellowship
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
242521
Name
Conroy Andrea
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
The Impact of HIV-1 and Malaria Co-infection on Angiogenesis, Fetal Development and Pregnancy Outcome in Sub-Saharan Africa.
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Co-Infection; Fetal Growth Restriction; Hiv-1; Immunity; Inflammation; Kenya; Malaria; Mother-To-Child Transmission Of Hiv; Pregnancy; Vascular Development
Abstract
Approximately 70% of people infected with HIV reside in sub-Saharan Africa. Women are particularly susceptible to HIV, with HIV rates 3 to 6-times higher in young women than men. Sub-Saharan Africa is also home to 30 million women at risk of contracting malaria during pregnancy each year and HIV increases the severity of malaria in pregnancy. When a mother is HIV positive, her fetus is at increased risk of being born growth restricted and of contracting HIV. Given the overlap between malaria and HIV in sub-Saharan Africa, we believe that malaria in pregnancy may increase the risk of the fetus contracting HIV from its mother. We believe this may occur as malaria initiates an immune response that activates fetal immune cells making them more susceptible to HIV infection. Further, malaria is known to increase the amount of HIV virus in the body, which relates to increased risk of transmission.
During pregnancy, angiogenic factors-proteins that circulate and are directly measureable in the blood- are responsible for coordinating the formation of blood vessels. Altered levels of these angiogenic factors have been associated with impaired fetal growth in preeclampsia and malaria, two major causes of fetal growth restriction globally. HIV is also associated with fetal growth restriction and we hypothesize that altered levels of angiogenic factors may contribute to HIV-related growth restriction.
In the work proposed, we will recruit and follow women throughout pregnancy. At antenatal visits, women will receive standard care including the administration of antiretroviral drugs to limit the risk of the fetus contracting HIV. In addition, a small blood sample will be collected for study purposes. We will measure whether changes in angiogenic proteins in HIV positive women are related to fetal growth restriction and we will determine whether malaria increases the ability of HIV to invade fetal cells.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Conroy, Andrea
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~